NASDAQ | ETF
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents.
It is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| MORF | Morphic Holding Inc | Healthcare | Biotechnology | 1000.00% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 8.59% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 7.93% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 7.63% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 7.40% |
| IQV | IQVIA Holdings Inc | Healthcare | Diagnostics & Research | 3.58% |
| ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 3.05% |
| ARGX | argenx NV ADR | Healthcare | Biotechnology | 2.92% |
| MTD | Mettler-Toledo International Inc | Healthcare | Diagnostics & Research | 2.57% |
| BNTX | BioNTech SE | Healthcare | Biotechnology | 2.37% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 2.24% |
| WAT | Waters Corporation | Healthcare | Diagnostics & Research | 2.23% |
| ILMN | Illumina Inc | Healthcare | Diagnostics & Research | 2.18% |
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 2.09% |
| UTHR | United Therapeutics Corporation | Healthcare | Biotechnology | 1.62% |
| GMAB | Genmab AS | Healthcare | Biotechnology | 1.43% |
| NBIX | Neurocrine Biosciences Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 1.40% |
| INCY | Incyte Corporation | Healthcare | Biotechnology | 1.39% |
| BGNE | BEIGENE ADS REPRESENTING LTD | null | null | 1.37% |
| ITCI | Intracellular Th | Healthcare | Drug Manufacturers - Specialty & Generic | 1.28% |